Michelle C. Mendoza - Concepedia

Author

Michelle C. Mendoza

Also Known As

M Mendoza, M. C. Mendoza, M. Mendoza, Maria Krisvie Abigale F. Mendoza, Michelle C Mendoza, Michelle C. Mendoza, Michelle Mendoza, Michelle C. Mendoza

Publications

4.5K

Citations

H-Index

Concepts

All Affiliations

University of Utah California Pacific Medical Center Harvard University Huntsman Cancer Institute The University of Texas Southwestern Medical Center

About

Michelle C. Mendoza is an author at University of Utah specializing in medicine, cell biology, and cell signaling.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	14	1.5K
2	Health Sciences	2	2	395
3	Natural Sciences	2	2	64
4	Engineering	1	1	40
5	Applied Physiology	1	1	153

Michelle C. Mendoza

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Emergency department point-of-care ultrasound in out-of-hospital and in-ED cardiac arrest Romolo Gaspari, Anthony J. Weekes, Srikar Adhikari, Resuscitation Medical UltrasoundEmergency CareMedicinePatient SafetyOut-of-hospital Emergency Medical Service	2016	265
The natural history of amyotrophic lateral sclerosis S. P. Ringel, J. R. Murphy, Margit Alderson, Neurology AgingDisease ProgressionNeurological DisorderHomogeneous SubgroupsNeurology	1993	242
PCAF Modulates PTEN Activity Kōichi Okumura, Michelle C. Mendoza, Robert Bachoo, Journal of Biological Chemistry Pten ActivitySignal TransductionCell RegulationSignaling PathwayPten Protein	2006	219
Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosis Robert G. Miller, Dan H. Moore, Deborah Gelinas, Neurology	2001	210
ERK-MAPK Drives Lamellipodia Protrusion by Activating the WAVE2 Regulatory Complex Michelle C. Mendoza, Ekrem Emrah Er, Wenjuan Zhang, Molecular Cell BiologyPattern FormationDevelopmental BiologySignal TransductionMorphogenesis	2011	173
Placebo-controlled trial of gabapentin in patients with amyotrophic lateral sclerosis Robert G. Miller, Donna Moore, Leroy Young, Neurology Neurological DisorderAlzheimer's DiseaseKinesiologyVital CapacityApplied Physiology	1996	153
AKT Facilitates EGFR Trafficking and Degradation by Phosphorylating and Activating PIKfyve Ekrem Emrah Er, Michelle C. Mendoza, Ashley Mackey, Science Signaling	2013	102
A placebo-controlled trial of gabapentin in spinal muscular atrophy Robert G. Miller, Dan H. Moore, V. Dronsky, Journal of the Neurological Sciences Clinical TrialsPlacebo-controlled TrialPharmacotherapyNeurologyNeurorehabilitation	2001	100
ERK reinforces actin polymerization to power persistent edge protrusion during motility Michelle C. Mendoza, Marco Vilela, Jesus E. Juarez, Science Signaling	2015	99
An analysis of disease severity based on SMN2 copy number in adults with spinal muscular atrophy Bakri Elsheikh, Thomas W. Prior, Xiaoli Zhang, Muscle & Nerve	2009	94

Page 1